| Financial Year |
March 31 2023 |
| Monetary Funds |
123,144,449.57 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
129,573,514.41 |
| Accounts Receivable |
428,015,265.62 |
| Advances to Suppliers |
17,743,305.48 |
| Other Receivables |
5,122,225.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
514,339,533.98 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,622,585.72 |
| Total Current Assets |
1,344,512,474.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
51,244,345.64 |
| Investment Properties |
33,162,992.37 |
| Fixed Assetes |
358,051,723.25 |
| Under-construction Projects |
6,924,649.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,438,102.70 |
| R&D expenses |
-- |
| Goodwill |
217,253,302.11 |
| Long-Term Deferred and Prepaid Expenses |
1,491,726.88 |
| Deferred Income Tax Assets |
22,792,516.28 |
| Other Non-Current Assets |
12,059,220.96 |
| Sub-Total of Non-Current Assets |
781,211,683.33 |
| Total Assets |
2,125,724,157.49 |
| Short-Term Loans |
108,715,739.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
88,581,766.70 |
| Accounts Payable |
246,096,554.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
24,332,111.85 |
| Taxes Payable |
7,723,007.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,287,508.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,221,477.09 |
| Other Current Liabilities |
38,366,826.57 |
| Sub-Total of Current Liabilities |
591,614,631.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
633,946.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,607,182.12 |
| Total Liabilities |
607,221,813.56 |
| Paid-In Capital(Or Share Stock) |
425,035,113.00 |
| Capital Surplus |
343,750,140.66 |
| Surplus Reserve |
113,941,816.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
625,612,425.66 |
| Minority Stockholder's Interest |
10,162,848.06 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,508,339,495.87 |
| Owner's Equity（Stockholder's Equity） |
1,518,502,343.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,125,724,157.49 |
